Kim M Keeling - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kim M Keeling

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

American Journal of Respiratory and Critical Care Medicine|April 23, 2016

Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense MutationsVenkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.

International Journal of Molecular Sciences|March 11, 2023

Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome)Amna Siddiqui, Halil Dundar, Jyoti Sharma, et al.

Nature Communications|July 17, 2021

A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletionJyoti Sharma, Ming Du, Eric Wong, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

American Journal of Respiratory and Critical Care Medicine|April 23, 2016

Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense MutationsVenkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.

International Journal of Molecular Sciences|March 11, 2023

Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome)Amna Siddiqui, Halil Dundar, Jyoti Sharma, et al.

Nature Communications|July 17, 2021

A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletionJyoti Sharma, Ming Du, Eric Wong, et al.

Pageof 4